Unknown

Dataset Information

0

Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States.


ABSTRACT:

Background

The possibility of incorporating generics into combination antiretroviral therapy and breaking apart once-daily single-tablet regimens (STRs), may result in less efficacious medications and/or more complex regimens with the expectation of marked monetary savings. A modeling approach that assesses the merits of such policies in terms of lifelong costs and health outcomes using adherence and effectiveness data from real-world U.S. settings.

Methods

A comprehensive computer-based microsimulation model was developed to assess the lifetime health (life expectancy and quality adjusted life-years--QALYs) and economic outcomes in HIV-1 infected patients initiating STRs compared with multiple-table regimens including generic medications where possible (gMTRs). The STRs considered included tenofovir disoproxil fumarate/emtricitabine and efavirenz or rilpivirine or elvitegravir/cobicistat. gMTRs substitutions included each counterpart to STRs, including generic lamivudine for emtricitabine and generic versus branded efavirenz.

Results

Life expectancy is estimated to be 1.301 years higher (discounted 0.619 QALY gain) in HIV-1 patients initiating a single-tablet regimen in comparison to a generic-based multiple-table regimen. STRs were associated with an average increment of $26,547.43 per patient in medication and $1,824.09 in other medical costs due to longer survival which were partially offset by higher inpatients costs ($12,035.61) with gMTRs treatment. Overall, STRs presented incremental lifetime costs of $16,335.91 compared with gMTRs, resulting in an incremental cost-effectiveness ratio of $26,383.82 per QALY gained.

Conclusions

STRs continue to represent good value for money under contemporary cost-effectiveness thresholds despite substantial price reductions of generic medications in the U. S.

SUBMITTER: Sweet DE 

PROVIDER: S-EPMC4725959 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5411186 | biostudies-literature
| S-EPMC9087297 | biostudies-literature
| S-EPMC4772845 | biostudies-literature
| S-EPMC3638200 | biostudies-other
| S-EPMC10397968 | biostudies-literature
| S-EPMC5289500 | biostudies-literature
| S-EPMC4108118 | biostudies-literature
| S-EPMC6805137 | biostudies-literature
| S-EPMC7070788 | biostudies-literature
| S-EPMC5118181 | biostudies-literature